<http://webisa.webdatacommons.org/prov/299783395>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/413472342> .
<http://webisa.webdatacommons.org/413472342>	<http://www.w3.org/ns/prov#value>	"Already the world leader in drugs for multiple sclerosis, Weston, Mass.-based Biogen is intent on finding new compounds to treat MS and other neurodegenerative diseases, banking on stepped up internal research and outside deals." .
<http://webisa.webdatacommons.org/413472342>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/413472342>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<investorplace.com> .